A specific point-of-care screen for infectious pleural effusions using reagent strips.

REFERENCES 1 Brockow K, Romano A, Blanca M, et al. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57: 45–51. 2 Janier M, Froidevaux D, Lons-Danic D, et al. Acute generalized exanthematous pustulosis due to the combination of chloroquine and proguanil. Dermatology 1998; 196: 271. 3 Luong MS, Bessis D, Raison-Peyron N, et al. Severe mucocutaneous necrotizing vasculitis associated with the combination of chloroquine and proguanil. Acta Derm Venereol 2003; 83: 141. 4 Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996; 15: 250–257. 5 Chen YC, Chiu HC, Chu CY. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol 2010; 146: 1373–1379. 6 Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007; 156: 609–611. 7 Santiago F, Goncalo M, Vieira R, et al. Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS). Contact Dermatitis 2010; 62: 47–53.